Concise review: Harnessing iPSC-derived cells for ischemic heart disease treatment

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Ischemic heart disease (IHD) is one of the most common cardiovascular diseases and is the leading cause of death worldwide. Stem cell therapy is a promising strategy to promote cardiac regeneration and myocardial function recovery. Recently, the generation of human induced pluripotent cells (hiPSCs) and their differentiation into cardiomyocytes and vascular cells offer an unprecedented opportunity for the IHD treatment. This review briefly summarizes hiPSCs and their differentiation, and presents the recent advances in hiPSC injection, engineered cardiac patch fabrication, and the application of hiPSC derived extracellular vesicle. Current challenges and further perspectives are also discussed to understand current risks and concerns, identify potential solutions, and direct future clinical trials and applications.

Original languageEnglish (US)
Pages (from-to)20-25
Number of pages6
JournalJournal of Translational Internal Medicine
Volume8
Issue number1
DOIs
StatePublished - May 9 2020

Keywords

  • Cardiomyocytes
  • cardiac patch
  • exosome
  • heart failure
  • myocardial infarction
  • vascularization

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Concise review: Harnessing iPSC-derived cells for ischemic heart disease treatment'. Together they form a unique fingerprint.

Cite this